Diabetes, obesity, and the metabolic syndrome: a call for papers for EASD and the World Diabetes Congress

2015 ◽  
Vol 3 (8) ◽  
pp. 591
Author(s):  
Philippa Berman ◽  
Justine Davies ◽  
Richard Horton
Metabolites ◽  
2021 ◽  
Vol 11 (5) ◽  
pp. 267
Author(s):  
Anna Bartosiewicz ◽  
Edyta Łuszczki ◽  
Małgorzata Nagórska ◽  
Łukasz Oleksy ◽  
Artur Stolarczyk ◽  
...  

The metabolic syndrome, also known as syndrome X or the insulin resistance, is defined by the World Health Organization as a pathologic condition characterized by abdominal obesity, insulin resistance, hypertension, and hyperlipidemia. Both all over the world and in Poland, there is a shortage of nurses; most of those employed are in the pre-retirement age. However, the requirements in this profession and the patient’s right to care at the highest level remain unchanged and do not take into account the poor condition or age of working nurses, so special attention should be paid to the state of health in this professional group. There is an emphasis on the importance of the adopted attitude toward health and the resulting behaviors, such as regular weight control, following dietary recommendations, regular physical activity and participation in preventive examinations. The aim of the study was to assess the frequency of the occurrence of the metabolic syndrome, its individual components and determining the factors influencing its development in Polish nurses. The research conducted among the nurses in question included DXA (Dual Energy X-ray Absorptiometry) measurements, assessment of glucose concentration, lipid profile, blood pressure and a questionnaire survey. Almost half of the surveyed nurses have metabolic syndrome, which significantly increases the risk of developing cardiovascular diseases or diabetes. After multivariate analysis, it was found that being overweight and obesity were significant factors influenced the MS (metabolic syndrome) occurrence among Polish nurses. Being overweight increases the chances of MS occurrence 8.58 times in relation to BMI (Body Mass Index) <25, obesity increases the chances of MS occurrence 8.085 times in relation to BMI <25, and obesity class II/III increases the chances of MS occurrence 16.505 times in relation to BMI <25. Preventive and supportive measures for this professional group are needed.


2016 ◽  
Vol 11 (1) ◽  
pp. 33-43 ◽  
Author(s):  
Dragana Lovre ◽  
Sarah H. Lindsey ◽  
Franck Mauvais-Jarvis

The world population is aging, and women will spend an increasing share of their lives in a postmenopausal state that predisposes to metabolic dysfunction. Thus, the prevalence of metabolic syndrome (MetS) in women is likely to increase dramatically. This article summarizes the effects of menopause in predisposing to components of MetS including visceral obesity, dyslipidemia, type 2 diabetes (T2D) and hypertension (HTN). We also summarize the effects of menopausal hormone therapy (MHT) in reversing these metabolic alterations and discuss therapeutic advances of novel menopausal treatment on metabolic function.


The Lancet ◽  
2015 ◽  
Vol 386 (9988) ◽  
pp. 13 ◽  
Author(s):  
Philippa Berman ◽  
Justine Davies ◽  
Richard Horton

2019 ◽  
Vol 4 (2) ◽  
Author(s):  
Nazwirman Nazwirman ◽  
Juniarti Juniarti ◽  
Yurika Sandra

Obesity is a health problem throughout the world. Obesity as a component of the metabolic syndrome, is very complex and multifactorial. Obesity is generally caused by energy input exceeding the body's use of energy for the sake of basal metabolism, physical activity, food waste disposal and for growth. The city of Tangerang ranks first for the prevalence of obesity from Banten Province. The results of the activity stated that the prevalence of obesity in Taklim women was 44 percent. This program is an empowerment of Majelis Taklim women to overcome and prevent health problems, especially metabolic syndrome by conducting screening and counseling. The result is that participants can know the symptoms and signs of metabolic syndrome through anthropometric measurements and laboratory tests, participants can know how to prevent metabolic syndrome and can provide explanations to the family and the surrounding community about prevention of metabolic syndrome


Author(s):  
Chittipolu Ajaykumar

Metabolic syndrome is an interrelated cluster of pathogens such as obesity, impaired glucose tolerance, cancer, and insulin resistance leading to endocrinal disorders. In the 21st century, progression of the disease is rapid increases due to change in the lifestyle of humans having a chance to develop metabolic change, and in some cases, mutations occur, which drastically affects the endocrine functionality and subsequently causes syndrome X. In modern medicine, different medications are available but only to maintain the condition lifetime. For the complete cure, WHO focused on the traditional knowledge in 2004, using the herbal medicine to cure all metabolic aliments. According to ancient medical treatment, metabolic syndromes are completely curable. They divided the disease progression stages and formulated the different dosage forms. All the data obtained from the ancient herbal medicine treatment are not evidence-based. So, the researchers all around the world focused on the evidence-based proofs to confirm whether herbal medicine shows efficacy in curing the metabolic syndrome or not.


2007 ◽  
Vol 66 (2) ◽  
pp. 198-206 ◽  
Author(s):  
Elizabeth C. Cottrell ◽  
Susan E. Ozanne

The increasing prevalence of the metabolic syndrome in numerous populations throughout the world is currently of major concern, and presents a huge global health problem. The link between low birth weight and the subsequent development of obesity, disrupted glucose homeostasis and hypertension is now well established, and there is extensive evidence supporting these associations in both epidemiological and experimental studies. Alterations in the secretion of, and responses to, the circulating hormones insulin and leptin are likely candidates in terms of disease development. The aim of current research is to define how the central and peripheral pathways in which these signals exert their effects may be disrupted following poor early growth, and how this disruption contributes to the development of metabolic disease. The present review aims to outline the existing evidence whereby alterations in early growth may programme an individual to be at increased risk of the metabolic syndrome. The development of central appetite and expenditure circuits and of peripheral metabolic tissues, are likely to play a key role in the long-term regulation of energy balance.


Medicina ◽  
2010 ◽  
Vol 46 (1) ◽  
pp. 61 ◽  
Author(s):  
Dalia Lukšienė ◽  
Miglė Bacevičienė ◽  
Abdonas Tamošiūnas ◽  
Liucija Černiauskienė ◽  
Lilija Margevičienė ◽  
...  

The aim of this study was to compare the prevalence of the metabolic syndrome diagnosed using three different definitions and to evaluate its associations with ischemic heart disease in Kaunas adult population. Material and methods. Data of preventive screening carried out in Kaunas in 2001–2002 according to the MONICA study protocol were used for analysis; a total of 1336 persons aged 35–64 years (603 men and 733 women) were recruited. The metabolic syndrome was defined by the World Health Organization, Adult Treatment Panel III, and International Diabetes Federation definitions. Ischemic heart disease was diagnosed based on the following criteria: a documented history of myocardial infarction, angina pectoris, or ischemic changes on electrocardiogram. Results. The metabolic syndrome was identified for 11.3% of men and for 9.4% of women using the World Health Organization definition, for 19.4% of men and for 26.3% of women using the Adult Treatment Panel III definition, and for 30.0% of men and for 37.7% of women using the International Diabetes Federation definition. In male and female groups, the prevalence of the metabolic syndrome (irrespective of definition) significantly increased with age (P<0.05). After adjusting for age, men diagnosed with the metabolic syndrome using the International Diabetes Federation definition (OR=2.30; P=0.001) and Adult Treatment Panel III definition (OR=1.97; P=0.01) and women diagnosed with metabolic syndrome using the International Diabetes Federation definition (OR=1.50; P=0.039) had a significantly higher risk of having ischemic heart disease as compared with those without the metabolic syndrome by the same definitions. The metabolic syndrome diagnosed using the World Health Organization definition was not associated with a significant risk of ischemic heart disease in men and women. Conclusion. In Kaunas population aged 35–64 years, the highest prevalence of the metabolic syndrome was determined according to the International Diabetes Federation definition. Usage of the International Diabetes Federation and the Adult Treatment Panel III definitions in establishing diagnosis of the metabolic syndrome provides more opportunities to identify subjects with ischemic heart disease.


Sign in / Sign up

Export Citation Format

Share Document